ABBOTT LABORATORIESABT
時価総額
$2229.7億
PER
医療機器・診断・栄養製品の最大手。FreeStyle LibreのCGM、心血管デバイスやペースメーカー、AlinityやBinaxNOW等の診断システム、Similac等の栄養製品を展開。2023年4月にCSIを8.51億ドルで買収、2023年9月にBigfoot買収。世界約160カ国で展開。
| 2010年 12月31日 | 2011年 12月31日 | 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | 2024年 12月31日 | |
| Net earnings | 4,626 | - | - | 2,576 | 2,284 | 4,423 | 1,400 | 477 | 2,368 | 3,687 | 4,495 | 7,071 | 6,933 | 5,723 | 13,402 |
| Depreciation | 1,207 | 1,395 | 1,364 | 928 | 918 | 871 | 803 | 1,046 | 1,100 | 1,078 | 1,195 | 1,491 | 1,254 | 1,277 | 1,340 |
| Amortization of intangible assets | 1,417 | 1,649 | 1,420 | 791 | 630 | 601 | 550 | 1,975 | 2,178 | 1,936 | 2,132 | 2,047 | 2,013 | 1,966 | 1,878 |
| Share-based compensation | 387 | 383 | 433 | 262 | 246 | 292 | 310 | 406 | 477 | 519 | 546 | 640 | 685 | 644 | 673 |
| Investing and financing losses, net | -126 | -142 | -356 | -4 | -69 | 18 | -86 | -47 | -126 | -184 | -425 | -55 | -215 | -126 | -482 |
| Trade receivables | 395 | 670 | -36 | 113 | 195 | 171 | 177 | 207 | 190 | 275 | 924 | 383 | 68 | 356 | 691 |
| Inventories | -140 | 130 | 417 | 154 | 297 | 257 | 98 | -249 | 514 | 593 | 493 | 456 | 1,413 | 232 | 58 |
| Prepaid expenses and other assets | -553 | -413 | 35 | -131 | -30 | -57 | -113 | -109 | -23 | 138 | 627 | 312 | 75 | 542 | 796 |
| Trade accounts payable and other liabilities | - | 1,790 | -134 | -436 | -225 | -742 | -652 | 615 | 747 | 220 | 1,766 | 1,288 | 420 | -760 | 356 |
| Income taxes | -212 | -1,402 | -1,309 | -665 | 197 | 957 | -699 | 1,149 | -214 | -545 | -614 | -908 | -383 | -585 | -8,028 |
| Net Cash From Operating Activities | - | - | - | 3,324 | 3,675 | 2,966 | 3,203 | 5,570 | 6,300 | 6,136 | 7,901 | 10,533 | 9,581 | 7,261 | 8,558 |
| Acquisitions of property and equipment | 1,015 | 1,492 | 1,795 | 1,145 | 1,077 | 1,110 | 1,121 | 1,135 | 1,394 | 1,638 | 2,177 | 1,885 | 1,777 | 2,202 | 2,207 |
| Acquisitions of businesses and technologies, net of cash acquired | - | - | - | - | - | - | - | - | - | 170 | 42 | 187 | - | 877 | - |
| Proceeds from business dispositions | - | - | - | - | - | 230 | 25 | 6,042 | 48 | 48 | 58 | 134 | 48 | 40 | 1 |
| Purchases of investment securities | - | - | - | - | - | - | - | - | - | - | - | - | 185 | 159 | 169 |
| Proceeds from Sale of Other Investments | - | - | - | - | - | - | - | - | - | - | - | - | 152 | 43 | 28 |
| Other | 18 | -16 | -3 | -21 | -75 | -52 | -42 | -35 | -48 | -27 | -19 | -26 | -22 | -22 | -9 |
| Net Cash From (Used in) Investing Activities | -12,188 | - | - | -3,929 | -202 | 406 | -248 | -9,618 | -1,356 | -1,815 | -2,215 | -2,008 | -1,740 | -3,133 | -2,338 |
| Proceeds from (Repayments of) Short-Term Debt | -204 | -1,965 | 784 | 2,086 | 1,343 | -1,281 | -1,767 | -1,034 | -26 | - | 2 | -204 | 47 | 21 | -100 |
| Proceeds from Long-Term Debt and Debt Maturing in More than Three Months | - | - | - | - | - | - | - | - | - | - | - | - | 7 | 2 | 223 |
| Repayments of long-term debt and debt with maturities over 3 months | - | - | - | - | - | - | - | - | - | - | - | - | 753 | 2,498 | 660 |
| Purchases of common shares | 867 | 77 | 2,364 | 1,605 | 2,195 | 2,237 | 522 | 117 | 238 | 718 | 403 | 2,299 | 3,795 | 1,227 | 1,295 |
| Proceeds from stock options exercised | 328 | 969 | 1,850 | 395 | 429 | 314 | 248 | 350 | 271 | 298 | 245 | 255 | 167 | 167 | 264 |
| Dividends paid | - | - | - | - | - | - | 1,539 | 1,849 | 1,974 | 2,270 | 2,560 | 3,202 | 3,309 | 3,556 | 3,836 |
| Net Cash From (Used in) Financing Activities | -1,088 | - | - | -6,696 | -2,742 | -2,236 | 11,147 | -5,281 | -10,391 | -4,289 | -2,779 | -5,494 | -7,636 | -7,091 | -5,404 |
| Effect of exchange rate changes on cash and cash equivalents | - | - | - | - | - | - | - | - | -116 | -16 | 71 | -70 | -122 | -23 | -96 |
| Net Increase (Decrease) in Cash and Cash Equivalents | - | - | - | - | - | - | - | - | -5,563 | 16 | 2,978 | 2,961 | 83 | -2,986 | 720 |
| Income taxes paid | - | - | - | - | - | - | - | 570 | 740 | 930 | 970 | 1,941 | 1,864 | 1,475 | 1,723 |
| Interest paid | - | - | - | - | - | - | - | 917 | 845 | 677 | 549 | 544 | 563 | 662 | 604 |